1. Home
  2. KVHI vs CRBP Comparison

KVHI vs CRBP Comparison

Compare KVHI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

N/A

Current Price

$8.83

Market Cap

138.7M

Sector

Technology

ML Signal

N/A

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$8.33

Market Cap

134.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
CRBP
Founded
1978
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.7M
134.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
KVHI
CRBP
Price
$8.83
$8.33
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.60
AVG Volume (30 Days)
93.5K
191.4K
Earning Date
03-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$9,622,000.00
$4,822,272.00
Revenue This Year
$15.27
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
3.82
97.62
52 Week Low
$4.80
$4.64
52 Week High
$8.48
$20.56

Technical Indicators

Market Signals
Indicator
KVHI
CRBP
Relative Strength Index (RSI) 68.88 44.15
Support Level $5.44 $7.45
Resistance Level N/A $8.63
Average True Range (ATR) 0.61 0.66
MACD 0.24 -0.12
Stochastic Oscillator 81.01 20.21

Price Performance

Historical Comparison
KVHI
CRBP

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: